GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tuoxin Pharmaceutical Group Co Ltd (SZSE:301089) » Definitions » Ending Cash Position

Tuoxin Pharmaceutical Group Co (SZSE:301089) Ending Cash Position : ¥289.2 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Tuoxin Pharmaceutical Group Co Ending Cash Position?

Tuoxin Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥289.2 Mil.

Tuoxin Pharmaceutical Group Co's quarterly Ending Cash Position declined from Sep. 2023 (¥288.8 Mil) to Dec. 2023 (¥130.7 Mil) but then increased from Dec. 2023 (¥130.7 Mil) to Mar. 2024 (¥289.2 Mil).

Tuoxin Pharmaceutical Group Co's annual Ending Cash Position increased from Dec. 2021 (¥234.3 Mil) to Dec. 2022 (¥301.3 Mil) but then declined from Dec. 2022 (¥301.3 Mil) to Dec. 2023 (¥130.7 Mil).

Tuoxin Pharmaceutical Group Co Ending Cash Position Historical Data

The historical data trend for Tuoxin Pharmaceutical Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tuoxin Pharmaceutical Group Co Ending Cash Position Chart

Tuoxin Pharmaceutical Group Co Annual Data
Trend Dec12 Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.92 67.37 234.34 301.35 130.73

Tuoxin Pharmaceutical Group Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.42 86.30 288.78 130.73 289.17

Tuoxin Pharmaceutical Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Tuoxin Pharmaceutical Group Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=301.349+-170.616
=130.7

Tuoxin Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=130.733+158.435
=289.2

Tuoxin Pharmaceutical Group Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Tuoxin Pharmaceutical Group Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Tuoxin Pharmaceutical Group Co (SZSE:301089) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tuoxin Pharmaceutical Group Co Ltd (SZSE:301089) » Definitions » Ending Cash Position
Comparable Companies
SHSE:603367 SZSE:002793 SHSE:688553 SZSE:300683 SZSE:301211 SHSE:600789 SHSE:605199 SZSE:300158 SHSE:600351 SZSE:301509 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 398, Jingquan West Road, High-tech Zone, Henan Province, Xinxiang, CHN, 453000
Website
http://www.tuoxinpharm.com
Tuoxin Pharmaceutical Group Co Ltd, formerly Xinxiang Tuoxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical synthesis and biological fermentation nucleoside APIs and pharmaceutical intermediates.

Tuoxin Pharmaceutical Group Co (SZSE:301089) Headlines

No Headlines